Researchers at Hokkaido University, in collaboration with an international team of scientists led by the University of South ...

PET-CT is not routinely needed for every colon cancer patient, but it can help in selected cases by identifying suspected ...

The FDA has approved atezolizumab plus chemotherapy as an adjuvant treatment for patients aged 2 years and older with stage ...

The Food and Drug Administration (FDA) approved Tecentriq (atezolizumab) in combination with chemotherapy on Oct. 8 as an ...

Colorectal cancer is, unfortunately, becoming more common in adolescents and young adults and represents a different disease ...

Colorectal cancer in young people is often diagnosed at an advanced stage, with researchers finding most patients age 21 or ...

The FDA has granted two Breakthrough Therapy Designations to telisotuzumab adizutecan (Temab-A, also known as ABBV-400), an ...

Genentech, part of Roche Group (USOTC:RHHBY), has received FDA approval for Tecentriq in combination with chemotherapy for a ...

More kids and teens are getting colorectal cancer. And when it does strike, researchers say the disease manifests differently ...

Tecentriq is now the first immunotherapy indicated for dMMR colon cancer treatment specifically, which is often linked to a higher risk of progression after surgery.

Exercise helped colon cancer survivors live longer in a major trial. But an October 6 report in The New York Times highlights ...

Cancer mortality for individuals aged under 50 years in Canada has significantly decreased for nine of the 10 deadliest ...